Caspases: structure-guided design of drugs to control cell death.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2008-09-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138955708785909899PMID 18855730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.

  2007cited by this paper
• Plasticity of S2–S4 specificity pockets of executioner caspase‐7 revealed by structural and kinetic analysis

  2007cited by this paper
• Clinical Trial of the Pan‐Caspase Inhibitor, IDN‐6556, in Human Liver Preservation Injury

  2007cited by this paper
• Novel irreversible caspase-1 inhibitor attenuates the maturation of intracellular interleukin-1beta.

  2007cited by this paper
• Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.

  2007cited by this paper
• Structure-activity based study of the Smac-binding pocket within the BIR3 domain of XIAP.

  2007cited by this paper
• The CASBAH: a searchable database of caspase substrates

  2007cited by this paper
• Caspase substrates

  2007cited by this paper
• Caspases in myocardial infarction.

  2007cited by this paper
• Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.

  2007cited by this paper
• A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.

  2007cited by this paper
• Caspase inhibitors: viral, cellular and chemical

  2007cited by this paper
• Oral IDN‐6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C

  2007cited by this paper
• Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.

  2006cited by this paper
• Isoquinoline‐1,3,4‐trione and its derivatives attenuate β‐amyloid‐induced apoptosis of neuronal cells

  2006cited by this paper
• Caspase function and the immune system.

  2006cited by this paper
• Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis

  2006cited by this paper
• Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms

  2006cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein.

  2006cited by this paper
• Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors.

  2006cited by this paper
• Caspases at the crossroads of immune-cell life and death

  2006cited by this paper
• Coordinated Expression of Caspase 8, 3 and 7 mRNA in Temporal Cortex of Alzheimer Disease: Relationship to Formic Acid Extractable A&bgr;42 Levels

  2006cited by this paper
• Morphological aspects of apoptosis in heart diseases

  2006cited by this paper
• Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis

  2006cited by this paper
• Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.

  2006cited by this paper
• Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.

  2006cited by this paper
• Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

  2006cited by this paper
• 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.

  2006cited by this paper
• Targeting XIAP for the treatment of malignancy

  2006cited by this paper
• Caspases: pharmacological manipulation of cell death.

  2005cited by this paper
• Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-diones.

  2005cited by this paper
• Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.

  2005cited by this paper
• Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas

  2005cited by this paper
• CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas.

  2005cited by this paper
• Apoptosis-based therapies and drug targets

  2005cited by this paper
• Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: peptidomimetic replacement of the P2 alpha-amino acid by a alpha-hydroxy acid.

  2005cited by this paper
• Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

  2005cited by this paper
• N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.

  2005cited by this paper
• 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.

  2005cited by this paper
• Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis.

  2004cited by this paper
• The protein structures that shape caspase activity, specificity, activation and inhibition.

  2004cited by this paper
• Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease

  2004cited by this paper
• Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.

  2004cited by this paper
• A Caspase-6 and Anti-Human Epidermal Growth Factor Receptor-2 (HER2) Antibody Chimeric Molecule Suppresses the Growth of HER2-Overexpressing Tumors1

  2004cited by this paper
• A Substrate-Phage Approach for Investigating Caspase Specificity

  2004cited by this paper
• Caspases: potential targets for regulating cell death

  2004cited by this paper
• Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

  2004cited by this paper
• Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors*

  2004cited by this paper
• Prospects for caspase inhibitors.

  2004cited by this paper
• Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer.

  2004cited by this paper
• Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors.

  2004cited by this paper
• A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.

  2004cited by this paper
• Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.

  2003cited by this paper
• Direct activation of the apoptosis machinery as a mechanism to target cancer cells

  2003cited by this paper
• Inactivating mutations of caspase-8 gene in colorectal carcinomas.

  2003cited by this paper
• Mechanisms of caspase activation.

  2003cited by this paper
• Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway*

  2003cited by this paper
• Caspase activation in neuronal and glial apoptosis following spinal cord injury in mice.

  2003cited by this paper
• Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.

  2003cited by this paper
• A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.

  2002cited by this paper
• Potent and selective nonpeptide inhibitors of caspases 3 and 7.

  2001cited by this paper
• Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis

  2001cited by this paper
• From bench to clinic with apoptosis-based therapeutic agents

  2000cited by this paper
• Neuroprotection by the Inhibition of Apoptosis

  2000cited by this paper
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

  2000cited by this paper
• Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.

  2000cited by this paper
• Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality*

  2000cited by this paper
• Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8.

  2000cited by this paper
• The atomic-resolution structure of human caspase-8, a key activator of apoptosis.

  1999cited by this paper
• The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

  1999cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone*

  1997cited by this paper
• Substrate Specificities of Caspase Family Proteases*

  1997cited by this paper
• A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B

  1997cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper

• Caspase-3 Activators as Anticancer Agents.

  2023cites this paper
• A long way to go: caspase inhibitors in clinical use

  2021cites this paper
• Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators.

  2019cites this paper
• Dietary butylated hydroxytoluene improves lipid metabolism, antioxidant and anti‐apoptotic response of largemouth bass (Micropterus salmoides)

  2018cites this paper
• Promising Caspases Modulators With Flavonoid Scaffold

  2015cites this paper
• Compressed images for affinity prediction-2 (CIFAP-2): an improved machine learning methodology on protein–ligand interactions based on a study on caspase 3 inhibitors

  2015cites this paper
• Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model

  2014cites this paper
• Pharmacological doses of melatonin induce alterations in mitochondrial mass and potential, bcl‐2 levels and K+ currents in UVB‐exposed U937 cells

  2013cites this paper
• Quantitative studies of caspase-3 catalyzed αII-spectrin breakdown.

  2013cites this paper
• The role of caspase-1 in liver and adipose tissue during metabolic dysregulation in mouse models on NASH

  2013cites this paper
• zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.

  2012cites this paper
• Reaction intermediates discovered in crystal structures of enzymes.

  2012cites this paper
• Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis

  2011cites this paper
• Allosteric modulation of caspases.

  2011influential citation
• Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling

  2009cites this paper
• Structural basis of caspase-3 substrate specificity revealed by crystallography, enzyme kinetics, and computational modeling

  2009cites this paper